FMC price target lowered to $15.50 from $17 at Morgan Stanley

Core Viewpoint - Morgan Stanley has lowered its price target on FMC to $15.50 from $17 while maintaining an Equal Weight rating on the shares [1] Group 1: Price Target and Rating - The price target for FMC has been reduced to $15.50 from $17 [1] - Morgan Stanley continues to hold an Equal Weight rating on FMC shares [1] Group 2: Future Outlook - The firm has lowered its estimates but believes that the most likely outcome for FMC involves a joint venture or license agreement concerning its four new patented molecules [1] - There is potential for co-development of the remaining R&D pipeline as part of this outcome [1]